Our collaborative work with Dr. Gold and his team underscores the potential of combining blood biomarkers and brain imaging to identify early signs of vascular contributions to cognitive decline. By measuring levels of S100b, an indirect marker of blood-brain barrier leakage, and pairing it with advanced neuroimaging, we identified patterns associated with memory loss in older adults. The findings underscore how a multimodal approach can better predict who’s at risk for vascular cognitive impairment and dementia (VCID).
Hady presents at the Trainee Research Day
Hady presented a poster on anti-amyloid antibodies and their effects on blood-brain barrier integrity at the College of Medicine Trainee Research Day. This work represents a new and timely research direction in the lab that aligns with the development of novel disease-modifying antibody therapeutics for Alzheimer’s disease.
March 23, 2026
